MAPT and amyloidosis: Notably, alterations in WM integrity, as measured through established MRI techniques, have been associated with both amyloid and tau pathology (55, 63, 64), providing a potential bridge between the pathological hallmarks of AD and the clinical manifestation of cognitive impairment.